Rest Easy with Intravenous Iron for Dialysis Patients? High Dose IV Iron Safety.
作者信息
Li Xiaojuan, Kshirsagar Abhijit V
机构信息
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts; and.
University of North Carolina Kidney Center and Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina.
出版信息
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):363-365. doi: 10.2215/CJN.00930118. Epub 2018 Feb 20.
Abstract
摘要
相似文献
1
Rest Easy with Intravenous Iron for Dialysis Patients? High Dose IV Iron Safety.透析患者静脉注射铁剂能高枕无忧吗？大剂量静脉注射铁剂的安全性
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):363-365. doi: 10.2215/CJN.00930118. Epub 2018 Feb 20.
2
Iron supplementation to treat anemia in patients with chronic kidney disease.补铁治疗慢性肾脏病患者的贫血。
Nat Rev Nephrol. 2010 Dec;6(12):699-710. doi: 10.1038/nrneph.2010.139. Epub 2010 Oct 19.
3
We Give Too Much Intravenous Iron.我们静脉注射铁剂过量。
Semin Dial. 2016 Jul;29(4):309-11. doi: 10.1111/sdi.12509. Epub 2016 May 7.
4
It's time to compare anemia management strategies in hemodialysis.现在是时候比较血液透析中的贫血管理策略了。
Clin J Am Soc Nephrol. 2010 Apr;5(4):740-2. doi: 10.2215/CJN.02490409. Epub 2010 Mar 18.
5
Renal Anemia and Iron Metabolism.肾性贫血与铁代谢
Contrib Nephrol. 2018;195:62-73. doi: 10.1159/000486936. Epub 2018 May 7.
6
IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy.血液透析患者的静脉铁剂治疗与贫血管理：修订后的持续质量改进策略的益处
Nephrol Nurs J. 2008 Jul-Aug;35(4):371-7, 394; quiz 378-9.
7
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.罗沙司他（FG - 4592）：对新进入透析患者贫血的纠正作用
J Am Soc Nephrol. 2016 Apr;27(4):1225-33. doi: 10.1681/ASN.2015030241. Epub 2015 Oct 22.
8
IV Iron: To Give or to Hold in the Presence of Infection in Adults Undergoing Hemodialysis.静脉注射铁剂：在接受血液透析的成年感染患者中，是给予还是停用。
Nephrol Nurs J. 2015 May-Jun;42(3):279-83; quiz 284.
9
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century.21世纪初透析患者的医源性铁过载
Drugs. 2016 May;76(7):741-57. doi: 10.1007/s40265-016-0569-0.
10
Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients.在血液透析患者中，每次给予极低剂量的直接静脉注射铁剂作为维持治疗。
Ren Fail. 2016 Aug;38(7):1076-81. doi: 10.1080/0886022X.2016.1184937. Epub 2016 May 19.
引用本文的文献
1
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations.终末期肾病（ESRD）和炎症性肠病（IBD）人群长期不加区分地使用静脉铁剂产品导致铁过载的风险。
Heliyon. 2019 Jul 12;5(7):e02045. doi: 10.1016/j.heliyon.2019.e02045. eCollection 2019 Jul.
2
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.随机对照试验比较前瞻性、高剂量与反应性、低剂量静脉铁补充在血液透析中的作用（关键）：研究设计和基线数据。
Am J Nephrol. 2018;48(4):260-268. doi: 10.1159/000493551. Epub 2018 Oct 10.
Zotero 插件